Menu
Share
 
Switch to Desktop Site

Why the US granted 'protected' status to Iranian terrorists

About these ads

The US State Department officially considers a group of 3,800 Marxist Iranian rebels - who once killed several Americans and was supported by Saddam Hussein - "terrorists."

But the same group, under American guard in an Iraqi camp, was just accorded a new status by the Pentagon: "protected persons" under the Geneva Convention.

This strange twist, analysts say, underscores the divisions in Washington over US strategy in the Middle East and the war against terrorism. It's also a function of the swiftly deteriorating US-Iran dynamic, and a victory for US hawks who favor using the Mujahideen-e Khalq Organization (MKO) or "People's Holy Warriors," as a tool against Iran's clerical regime.

"How is it that [the MKO] get the Geneva Convention, and the people in Guantánamo Bay don't get it? It's a huge contradiction," says Ali Ansari, a British expert on Iran. "This will be interpreted in Iran as another link in the chain of the US determination to move onto Iran next" in the US war on terror.

For months, Tehran has quietly signaled that it would turn over high-ranking Al Qaeda members in exchange for MKO members now in Iraq. The MKO's new status likely puts an end to any such deal.

The shift also comes as momentum builds in Washington to take some action against the Islamic republic. Wednesday, it was reported that Tehran has broken United Nations inventory seals and may resume work on constructing centrifuges - the machines used for enriching uranium.

Senior European diplomats - who brokered a private deal with Iran last October that included halting suspected nuclear weapons programs, in exchange for Western nuclear power expertise - are expected to secretly meet Iranian counterparts Thursday in London or Paris to see what can be salvaged of their agreement.

"US-Iran relations are drifting into very dangerous waters at the moment," says Mr. Ansari.

Next

Page 1 of 4


Follow Stories Like This
Get the Monitor stories you care about delivered to your inbox.

Loading...